Preoperative TNM evaluation of peripheral clinical stage I small cell lung cancer treated by initial lobectomy with adjuvant chemotherapy.

Surgery with chemotherapy has been the accepted procedure for treating pathological stage I small cell lung cancer. However, there is a question of whether all clinical stage I patients should undergo surgery or not because of discrepancies between clinical and pathological staging. We conducted a retrospective analysis of TNM evaluation and postoperative survival on 10 clinical stage IA (T1N0M0) and 6 stage IB (T2N0M0) patients who had undergone initial lobectomy followed by chemotherapy. Clinical stage IB showed a high incidence of hilar or mediastinal lymph node involvement than stage IA (P=0.04). The accuracy of the T-factor did not differ between both stages. The pathological mean dimension of primary tumors with lymph node metastasis (33.4 mm) was significantly larger than that without metastasis (22.1 mm) (P=0.04). The difference in survival between clinical stage IA (7 of 10) and stage IB (2 of 6) was large but not significant (P=0.07). Four patients in each clinical stage died of cancer relapses. When indicating surgery for clinical stage I small cell lung cancer, it should be taken into account that primary tumors of more than 30 mm in diameter may suggest the possibility of stages more advanced than pathological stage II because of a high incidence of lymph node metastasis.

[1]  Jeffrey D Bradley,et al.  Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  L. Krug,et al.  Surgery in the management of small cell lung cancer. , 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  B. Jeremic,et al.  Limited-disease small-cell lung cancer. , 2003, Seminars in surgical oncology.

[4]  K. Mori,et al.  Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. , 2002, The New England journal of medicine.

[5]  A. Pforte,et al.  Positron emission tomography in the staging of small-cell lung cancer : a preliminary study. , 2001, Chest.

[6]  S. Miyoshi,et al.  Surgical results for small cell lung cancer based on the new TNM staging system. Thoracic Surgery Study Group of Osaka University, Osaka, Japan. , 2000, The Annals of thoracic surgery.

[7]  H. Wada,et al.  Surgical treatment of small cell carcinoma of the lung: advantage of preoperative chemotherapy. , 1995, Lung cancer.

[8]  D. Sugarbaker,et al.  Surgical resection in the management of small-cell carcinoma of the lung. , 1993, Chest.

[9]  D. Ihde,et al.  Chemotherapy of Lung Cancer , 1992 .

[10]  A. Chella,et al.  Surgery Plus Adjuvant Chemotherapy for T1–3N0M0 Small‐Cell Lung Cancer: Rationale for Current Approach , 1991, American journal of clinical oncology.

[11]  R. Ginsberg,et al.  Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience. , 1991, The Journal of thoracic and cardiovascular surgery.

[12]  F. Parker,et al.  The prospect of disease control by surgery combined with chemotherapy in stage I and stage II small cell carcinoma of the lung. , 1983, The Annals of thoracic surgery.

[13]  W. Fox,et al.  Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. , 1973, Lancet.

[14]  E. Ulsperger,et al.  Surgery for cure followed by chemotherapy in small cell carcinoma of the lung. For the ISC-Lung Cancer Study Group. , 1995, Acta oncologica.